News Medical on MSN21h
BMI's influence on disease pathogenesis uncovered in new researchThe study highlights BMI's role in mediating genetic risk for diseases, suggesting a complex relationship with conditions ...
OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...
Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...
People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...
In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...
The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.
Niyondiko, N. (2024) Clinical Management of Diabetic Ketoacidosis in Pregnancy: A Review of Current Literature. Open Access Library Journal, 11, 1-25. doi: 10.4236/oalib.1112246 .
Akebia Therapeutics®, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the American Journal of Kidney Disease has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback